Semmelweis University (SE) is one of participating University Centres that established the first Diploma Course in Medicines Development (DiMD) using the PharmaTrain shared standards. SE now extends the Course with another six Modules, incl. two Electives, to a full Master of Medicines Development (MMD) in cooperation with other universities, the Cooperative European Medicines Development Course (CEMDC).
Sándor Kerpel- Fronius, SE, Budapest
“We are ready to provide a platform to strengthen your competence in bringing a medicine from molecule to market, what we call integrated medicines development.”
Behrouz KASSAI, MD, PhD, Pediatric Clinical Research and Investigation Centre, Lyon, FRANCE
“European Diploma In Pharmaceutical Medicine is a second-level Master according to the French academic rules accrediting 90 ECTS. The faculty comprises members from academia and industry from Europe and USA with experience in drug development. Since 2003, 15 students are enrolled each year. The program follows the Pharmatrain Syllabus and has been recognized as a centre of excellence in 2013. Each group of 3 students are tutored by a senior academic. During the first 6 months, they develop a case-study with their tutors and work on a specific topic concerning the drug development process. Their work is systematically presented at DIA European meeting. Students are offered during the second semester an internship with a placement in industry, CROs or academic hospitals. Students benefit also from the excellent environment offered by the city of Lyon.